Genetic disorders of neonatal respiratory function

Pediatric Research

Volumn 50, Issue 2, 2001, Pages 157-162

  Cole, F Sessions ^a   Hamvas, Aaron ^a   Nogee, Lawrence M ^b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

FAMILY HISTORY; GENETIC DISORDER; GENETIC MARKER; HUMAN; LUNG DISEASE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN DISEASE; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0034914109     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200108000-00001     Document Type: Review

References (89)

1. Annual summary of vital statistics, 1998
2. The long-term sequelae of prematurity: The role of familial airway hyperreactivity and the respiratory distress syndrome
3. Family history of asthma in infants with broncho-pulmonary dysplasia
4. Maternal asthma and transient tachypnea of the newborn
5. Bronchopulmonary dysplasia and family history of asthma
6. Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993
7. Surface properties in relation to atelectasis and hyaline membrane disease
8. Impact of advances in physiology, biochemistry, and molecular biology on pulmonary disease in neonates
9. Pulmonary surfactant therapy
10. Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500 to 1500 g
11. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994
12. Rehospitalization and growth of infants with bronchopulmonary dysplasia: A matched control study
13. Chronic lung disease following neonatal ventilation. II. Changing incidence in a geographically defined population
14. Bronchopulmonary dysplasia: Impact of surfactant replacement therapy
15. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia
16. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites
17. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice
18. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice
19. Surfactant proteins: Molecular genetics of neonatal pulmonary diseases
20. The influence of race and other factors on pulmonary hyaline membranes
21. Hyaline membrane disease: The role of ethnicity and maternal risk characteristics
22. Birth weight, gestational age, and sex as determining factors in the incidence of respiratory distress syndrome of prematurely born infants
23. Discordance between male and female deaths due to the respiratory distress syndrome
24. Racial differences in predictive value of the lecithin/sphingomyelin ratio
25. Hyaline membrane disease in black newborns: Does fetal lung maturation occur earlier?
26. Recurrent respiratory distress syndrome in successive preterm pregnancies
27. Familial lung disease associated with proliferation and desquamation of type II pneumocytes
28. A genetic and statistical study of the respiratory distress syndrome
29. Human SP-A locus: Allele frequencies and linkage disequilibrium between the two surfactant protein A genes
30. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes
31. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: Interaction with SP-B
32. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans
33. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population
34. Altered surfactant function and structure in SP-A gene targeted mice
35. Characteristics of surfactant from SP-A-deficient mice
36. Surfactant metabolism in surfactant protein A-deficient mice
37. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences
38. Collectins: Pattern recognition molecules involved in first line host defense
39. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
40. Surfactant protein-A deficient mice are susceptible to Pseudomonas aeruginosa infection
41. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
42. Human surfactant protein B: Structure, function, regulation, and genetic disease
43. Surfactant protein B processing in human fetal lung
44. Intracellular localization of processing events in human surfactant protein B biosynthesis
45. Brief report: Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis
46. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds
47. Pulmonary surfactant metabolism in infants lacking surfactant protein B
48. Aberrant processing of surfactant protein C in hereditary SP-B deficiency
49. Surfactant protein-B deficiency
50. Surfactant protein B deficiency: Insights into inherited disorders of lung cell metabolism
51. Surfactant protein B deficiency: Antenatal diagnosis and prospective treatment with surfactant replacement
52. Lung transplantation for treatment of infants with surfactant protein B deficiency
53. Transient surfactant protein B deficiency in a term infant with severe respiratory failure
54. Normal lung function in subjects heterozygous for surfactant protein-B deficiency
55. Partial deficiency of surfactant protein B in an infant with chronic lung disease
56. Rescue of SP-B knockout mice with a truncated SP-B proprotein: Function of the C-terminal propeptide
57. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation
58. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice
59. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome
60. Characterization of markers flanking the human SP-B locus
61. Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B)
62. Dinucleotide repeat polymorphism in the human surfactant-associated protein 3 gene (SFTP3)
63. An SP-B gene mutation responsible for SP-B deficiency in fatal congenital alveolar proteinosis: Evidence for a mutation hotspot in exon 4
64. Population-based estimates of surfactant protein B deficiency
65. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency
66. Function and regulation of expression of pulmonary surfactant-associated proteins
67. Structure and properties of surfactant protein C
68. Synthetic processing of surfactant protein C by alveolar epithelial cells: The COOH terminus of proSP-C is required for post-translational targeting and proteolysis
69. Generation of an SP-C deficient mouse by targeted gene inactivation
70. A mutation in the surfactant protein C (SP-C) gene associated with familial interstitial lung disease
71. Lung surfactant proteins involved in innate immunity
72. Immunomodulatory functions of surfactant
73. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D
74. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice
75. Genetics of the hydrophilic surfactant proteins A and D
76. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles
77. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
78. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression
79. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
80. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect
81. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice
82. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis
83. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography
84. Resequencing and mutational analysis using oligonucleotide microarrays
85. Genetics of complex disease-approaches, problems, and solutions
86. The genetic contribution to the phenotype
87. Integrated methods to solve the biological basis of common diseases
88. Stored Guthrie cards as DNA "banks."
89. Utility of PCR for DNA analysis from dried blood spots on filter paper blotters